Carmine Therapeutics
Cambridge, US · Founded 2021
Founders & leadership
HL
Harvey LodishDirector
LX
Lin XiangqianDirector
DH
Donald HautExecutive Officer, Director
EE
Elan EzicksonDirector
Reported raises · per SEC filings
Form D private placements▶$13.7MraisedNov 2022 · 6 investors · OtherRule 506(b)
▶$13.7MraisedNov 2022 · 6 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Harvey LodishDirector
- Lin XiangqianDirector
- Donald HautExecutive Officer, Director
- Elan EzicksonDirector
- Offering amount
- $13.7M
- Amount sold
- $13.7M
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.